BrainCool AB (publ) (STO:BRAIN)

Market Cap	356.97M +48.8%
Revenue (ttm)	46.49M +26.0%
Net Income	-34.43M
EPS	-0.10
Shares Out	394.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,454
Open	0.8940
Previous Close	0.8990
Day's Range	0.8760 - 0.9040
52-Week Range	0.4105 - 1.0100
Beta	1.44
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About BrainCool AB

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient’s temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient’s nostrils with a catheter; Cooral system provides medical professionals a way to reduce the ri...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 15
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BRAIN

Financial Performance

In 2025, BrainCool AB's revenue was 42.15 million, an increase of 5.46% compared to the previous year's 39.97 million. Losses were -37.05 million, -16.26% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error